Publication
, Other
Reddy, GB; Kerr, DL; Spasojevic, I; Tovmasyan, A; Hsu, DS; Brigman, BE; Somarelli, JA; Needham, D; Eward, WC
April 3, 2023
APA
Chicago
ICMJE
MLA
NLM
Reddy, G. B., Kerr, D. L., Spasojevic, I., Tovmasyan, A., Hsu, D. S., Brigman, B. E., … Eward, W. C. (2023). Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. https://doi.org/10.1158/1535-7163.c.6542728
Reddy, Gireesh B., David L. Kerr, Ivan Spasojevic, Artak Tovmasyan, David S. Hsu, Brian E. Brigman, Jason A. Somarelli, David Needham, and William C. Eward. “Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma,” April 3, 2023. https://doi.org/10.1158/1535-7163.c.6542728.
Reddy GB, Kerr DL, Spasojevic I, Tovmasyan A, Hsu DS, Brigman BE, et al. Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 2023.
Reddy, Gireesh B., et al. Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 3 Apr. 2023. Crossref, doi:10.1158/1535-7163.c.6542728.
Reddy GB, Kerr DL, Spasojevic I, Tovmasyan A, Hsu DS, Brigman BE, Somarelli JA, Needham D, Eward WC. Data from Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma. 2023.